Guilford (GLFD) - Steadily Rising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guilford (GLFD) - Steadily Rising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Bloxom who wrote (37)	3/24/1997 1:57:00 AM
From: SteveG	of 496

<When is Intel's conference call scheduled?> As you probably know, the conference call will follow the earnings report, which is schedule for one day the week of April 14. I have heard possibly the 17th, but nothing definitive yet. Tune in to one of Intel's SI threads for updates and a phone number. <BTW, I am a GLFD believer and stockholder; seems to me that there is potential for the wafer system in other solid tumor excision sites, apart from the stuff in the pipeline> I agree. Collaborations with RPR, JH and MIT wil likely yield broader wafer drug delivery applications and will be their near term cash generator. But my interest (both professionally and as an investor) is in the clinical trials they hope to have with their GPI-1046/1216. No revenue streams from these currently, but the market is vast, and a share of Guilford (in addition to Gliadel) is a not unreasonable raffle ticket. Keep in mind that this is a highly competitive field though, and breakthroughs come from unlikely corners (dig through November's Neuroscience abstracts). Regards- Steve

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next